BioAtla, Inc. (BCAB)
USD 0.27
(-8.07%)
USD 0.27
(-8.07%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -103.73 Million USD | -8551.46% |
| 2022 | -1.19 Million USD | -11.02% |
| 2021 | -1.08 Million USD | -364.02% |
| 2020 | 409.06 Thousand USD | -92.09% |
| 2019 | 5.17 Million USD | 133.0% |
| 2018 | -15.67 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -229 Thousand USD | 4.58% |
| 2024 Q1 | -240 Thousand USD | -117.94% |
| 2023 FY | -1.22 Million USD | -1.83% |
| 2023 Q1 | -293 Thousand USD | 1.68% |
| 2023 Q3 | -270 Thousand USD | 6.9% |
| 2023 Q4 | 1.33 Million USD | 595.56% |
| 2023 Q2 | -290 Thousand USD | 1.02% |
| 2022 Q3 | -300 Thousand USD | -4.17% |
| 2022 Q2 | -288 Thousand USD | 7.99% |
| 2022 Q1 | -313 Thousand USD | -389.06% |
| 2022 FY | -1.19 Million USD | -11.02% |
| 2022 Q4 | -298 Thousand USD | 0.67% |
| 2021 Q1 | -309 Thousand USD | 97.05% |
| 2021 FY | -1.08 Million USD | -364.02% |
| 2021 Q4 | -64 Thousand USD | 72.17% |
| 2021 Q3 | -230 Thousand USD | 98.42% |
| 2021 Q2 | -14.6 Million USD | -4624.92% |
| 2020 FY | 409.06 Thousand USD | -92.09% |
| 2020 Q2 | -2.73 Million USD | -73.85% |
| 2020 Q1 | -1.57 Million USD | -38.62% |
| 2020 Q3 | -4.71 Million USD | -72.48% |
| 2020 Q4 | -10.48 Million USD | -122.42% |
| 2019 Q4 | -1.13 Million USD | 0.0% |
| 2019 FY | 5.17 Million USD | 133.0% |
| 2018 FY | -15.67 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | 186.102% |
| Jaguar Health, Inc. | 7.72 Million USD | 1442.97% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -15522.139% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -2074520.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 106.834% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 186.621% |
| ContextLogic Inc. | 59 Million USD | 275.815% |
| MiMedx Group, Inc. | 266.84 Million USD | 138.873% |
| MEI Pharma, Inc. | 49.32 Million USD | 310.293% |
| AlloVir, Inc. | -398 Thousand USD | -25963.065% |
| Novavax, Inc. | 639.93 Million USD | 116.21% |
| Aptorum Group Limited | -1.11 Million USD | -9205.833% |
| Ardelyx, Inc. | 106.66 Million USD | 197.253% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 143.089% |
| Psyence Biomedical Ltd. | -240.00 USD | -43221150.0% |
| Vaxcyte, Inc. | -75 Million USD | -38.308% |
| Precigen, Inc. | 106 Thousand USD | 97959.434% |
| Pharming Group N.V. | 220.1 Million USD | 147.128% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 20241.942% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 10380.575% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 194.497% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 42.819% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -19973.885% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 19.911% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -128.86% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -371.783% |
| Acelyrin, Inc. | -115 Thousand USD | -90100.87% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -18066.55% |
| Senti Biosciences, Inc. | -2.68 Million USD | -3766.232% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 2660.627% |
| AbCellera Biologics Inc. | 38.02 Million USD | 372.797% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -2061.963% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 86542.5% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 456.109% |
| Chimerix, Inc. | 324 Thousand USD | 32115.741% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 21013.508% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -126401.22% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -232.816% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -20983.537% |
| Elevation Oncology, Inc. | -39 Thousand USD | -265876.923% |
| Alkermes plc | 1.37 Billion USD | 107.546% |
| Fortress Biotech, Inc. | 57.85 Million USD | 279.301% |
| Fortress Biotech, Inc. | 57.85 Million USD | 279.301% |
| Agenus Inc. | 139.61 Million USD | 174.298% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 725.753% |
| Dyadic International, Inc. | 922.95 Thousand USD | 11338.985% |
| ImmuCell Corporation | 4.39 Million USD | 2459.515% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 592.526% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 2.254% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -59228.083% |
| Immix Biopharma, Inc. | -5468.00 USD | -1896955.596% |
| Incyte Corporation | 3.44 Billion USD | 103.015% |
| IO Biotech, Inc. | -756 Thousand USD | -13621.032% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -121.463% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -676.555% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -234649.253% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -5.614% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -188501.818% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 13034.04% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -19583.302% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 452.983% |
| NextCure, Inc. | -3.68 Million USD | -2715.717% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 644.72% |
| Onconetix, Inc. | -1.12 Million USD | -9102.823% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -258.088% |
| Opthea Limited | 21.72 Thousand USD | 477682.873% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -180849.307% |
| PureTech Health plc | -1.6 Million USD | -6371.054% |
| Pyxis Oncology, Inc. | -2 Million USD | -5086.55% |
| Seer, Inc. | 7.02 Million USD | 1576.178% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -1031946.563% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1417.888% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -2531.399% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 24564.858% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 199.646% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 176.685% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -6.994% |
| ChromaDex Corporation | 50.78 Million USD | 304.275% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -44611.638% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -33.677% |
| CRISPR Therapeutics AG | 240.95 Million USD | 143.05% |
| Precision BioSciences, Inc. | 40.47 Million USD | 356.303% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -5.672% |
| Innoviva, Inc. | 261.06 Million USD | 139.734% |
| Summit Therapeutics Inc. | -2.05 Million USD | -4960.049% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 2469.37% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 581.462% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -87443.358% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -72286.794% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 17133.005% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 133.07% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 4129.953% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -204336.342% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1361.412% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -21759.044% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -997313.462% |
| Soligenix, Inc. | 97.31 Thousand USD | 106697.404% |
| Century Therapeutics, Inc. | -10.8 Million USD | -859.672% |
| Kura Oncology, Inc. | -849 Thousand USD | -12118.021% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -54.582% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -70465.306% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 204.738% |
| Autolus Therapeutics plc | -4.86 Million USD | -2031.313% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 350.643% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -61644.643% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 209.51% |
| GRI Bio, Inc. | 10.84 Million USD | 1056.84% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 4183.92% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -1094.095% |
| IGM Biosciences, Inc. | -211.66 Million USD | 50.992% |
| INmune Bio, Inc. | 155 Thousand USD | 67023.226% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 267.473% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -6786.518% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -15896.663% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -354245.153% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 25903.731% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -5096.944% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -33040.895% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 209.814% |
| Verastem, Inc. | -62 Thousand USD | -167208.065% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 4360.0% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -39643.678% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 3526.858% |
| Histogen Inc. | 3.76 Million USD | 2852.215% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 18103.259% |
| Surrozen, Inc. | -27.23 Million USD | -280.944% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1824.865% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -8509.239% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -304.457% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 617.31% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -5238839.394% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1809.92% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -154420.266% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 167.014% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 71246.091% |
| Apollomics, Inc. | 127 Thousand USD | 81777.953% |
| Amarin Corporation plc | 165.54 Million USD | 162.662% |
| Mesoblast Limited | -9.81 Million USD | -956.862% |
| Turnstone Biologics Corp. | 16.5 Million USD | 728.444% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 6.116% |
| Synaptogenix, Inc. | -6347.00 USD | -1634231.18% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -203294.118% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 164.283% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 105.902% |
| Better Therapeutics, Inc. | -2.72 Million USD | -3701.063% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 7.516% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 130.682% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -909182.959% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1557.045% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -9262.004% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1517.477% |
| Insmed Incorporated | 239.63 Million USD | 143.287% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 2999.134% |
| OmniAb, Inc. | 14.66 Million USD | 807.241% |
| Alector, Inc. | -95.05 Million USD | -9.13% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 182.575% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -138.665% |
| Zai Lab Limited | 170.9 Million USD | 160.696% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 226.691% |
| Aura Biosciences, Inc. | -1.29 Million USD | -7910.116% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 79893.077% |
| Immunic, Inc. | -111 Thousand USD | -93351.351% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 754.289% |
| Veracyte, Inc. | 248.14 Million USD | 141.802% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.516% |
| FibroGen, Inc. | 128.9 Million USD | 180.472% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -18391921.277% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -789.106% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 103.052% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 26766.067% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 129.192% |
| TG Therapeutics, Inc. | 219.1 Million USD | 147.342% |
| Galecto, Inc. | -830 Thousand USD | -12397.711% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -7389.603% |
| Fortrea Holdings Inc. | 424 Million USD | 124.465% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -20.384% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -18194.709% |
| XBiotech Inc. | -1.74 Million USD | -5847.878% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -9262.004% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -123.217% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -37.33% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 241.317% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 717.336% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 126.663% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -108.937% |
| Vaxxinity, Inc. | -2.23 Million USD | -4543.286% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 131.746% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -816.041% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 524.24% |
| NexImmune, Inc. | -1.02 Million USD | -10020.374% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 1921044.444% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1359.837% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.918% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -155123.188% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -2821.177% |
| Ainos, Inc. | -253.73 Thousand USD | -40781.951% |
| Pluri Inc. | 322 Thousand USD | 32314.596% |
| Prothena Corporation plc | -129.2 Million USD | 19.713% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 305.718% |
| Celularity Inc. | 6.75 Million USD | 1635.618% |
| Rallybio Corporation | -150 Thousand USD | -69054.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | -218.125% |
| MeiraGTx Holdings plc | 287 Thousand USD | 36243.206% |
| Omeros Corporation | -69.77 Million USD | -48.656% |
| Humacyte, Inc. | -76.55 Million USD | -35.508% |
| Immunocore Holdings plc | 248.39 Million USD | 141.761% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -583.835% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 266.284% |
| Blueprint Medicines Corporation | 236.58 Million USD | 143.845% |
| CalciMedica, Inc. | -58 Thousand USD | -178746.552% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -7174.264% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 457.016% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -3547.363% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -236.08% |
| Pulmatrix, Inc. | -8.22 Million USD | -1161.934% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -8765.897% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -25897.744% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 73.989% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 3837.266% |
| Cytokinetics, Incorporated | -322.59 Million USD | 67.845% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 12132.293% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -30319.648% |
| Vor Biopharma Inc. | -3.49 Million USD | -2870.533% |
| Roivant Sciences Ltd. | 109.23 Million USD | 194.961% |
| Evogene Ltd. | 1.39 Million USD | 7514.653% |
| ProKidney Corp. | -3.16 Million USD | -3173.304% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -136.225% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1612.775% |
| CorMedix Inc. | -205.56 Thousand USD | -50362.148% |
| BioLineRx Ltd. | 1.1 Million USD | 9462.004% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -31.854% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -314236.364% |
| Atai Life Sciences N.V. | -5000.00 USD | -2074520.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -85023.791% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -107953.125% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -7368.035% |
| Sagimet Biosciences Inc. | 2 Million USD | 5286.55% |
| MediciNova, Inc. | 979.7 Thousand USD | 10687.983% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -23.022% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -109604.405% |
| GeoVax Labs, Inc. | -20.72 Million USD | -400.614% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 142.42% |
| Biomea Fusion, Inc. | -4.2 Million USD | -2369.198% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 111.891% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1496.862% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -33361.613% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -864325.0% |
| Absci Corporation | -41.84 Million USD | -147.87% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2074520.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -35.822% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -4114.994% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 148.533% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -10923.486% |
| Allakos Inc. | -6.14 Million USD | -1589.155% |
| Imunon, Inc. | -720 Thousand USD | -14306.983% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -50.343% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 121.797% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -909182.959% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -58175.843% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 57.281% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -33254.019% |
| XOMA Corporation | 3.86 Million USD | 2786.636% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -48.007% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 801.169% |
| aTyr Pharma, Inc. | -2.38 Million USD | -4243.844% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 932.512% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -357593.103% |
| Viridian Therapeutics, Inc. | -1 Million USD | -10190.774% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 797930869.231% |
| Akari Therapeutics, Plc | -4000.00 USD | -2593175.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 116.287% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 53375.161% |
| UroGen Pharma Ltd. | 73.35 Million USD | 241.415% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -288.593% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 893562.532% |
| Orgenesis Inc. | -5.72 Million USD | -1711.895% |
| Entera Bio Ltd. | -56 Thousand USD | -185133.929% |
| GH Research PLC | -315 Thousand USD | -32830.476% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -54784.127% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -19658.286% |
| Xencor, Inc. | -85.26 Million USD | -21.664% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -46841.989% |
| Replimune Group, Inc. | -2.65 Million USD | -3807.006% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -10260.295% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 158.327% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 53375.161% |
| Portage Biotech Inc. | -54 Thousand USD | -191994.444% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -109604.405% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -27414.854% |
| OncoCyte Corporation | 413 Thousand USD | 25216.465% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -2307597.442% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -46725575.676% |
| Purple Biotech Ltd. | -196 Thousand USD | -52823.98% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1256.679% |
| scPharmaceuticals Inc. | 9.78 Million USD | 1160.427% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -893.12% |
| HilleVax, Inc. | -2.15 Million USD | -4711.271% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -106839.175% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -691255.638% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -15428.593% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -450904.348% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1381844.963% |
| Savara Inc. | -44.26 Million USD | -134.357% |
| Curis, Inc. | 9.81 Million USD | 1157.293% |
| Daré Bioscience, Inc. | 2.76 Million USD | 3845.448% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -83025.781% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -5899.479% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -45396.053% |
| BeiGene, Ltd. | 2.07 Billion USD | 104.99% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -3610.111% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 74.045% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 282.986% |
| Erasca, Inc. | -3.73 Million USD | -2679.502% |
| bluebird bio, Inc. | -4.03 Million USD | -2473.97% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -367505.784% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 105.447% |
| DBV Technologies S.A. | 15.72 Million USD | 759.531% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -367505.784% |
| Moderna, Inc. | 2.15 Billion USD | 104.814% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -11236.721% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1395.666% |
| Molecular Templates, Inc. | 50.39 Million USD | 305.836% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -19252.799% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 177.534% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1567.165% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -163.658% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 6.656% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -2791.054% |
| MacroGenics, Inc. | 50.52 Million USD | 305.298% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -1601.066% |
| Prime Medicine, Inc. | -147.9 Million USD | 29.866% |
| Aditxt, Inc. | -111.66 Thousand USD | -92798.979% |
| Adagene Inc. | 18.11 Million USD | 672.736% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 21356.352% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 173.987% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 165.721% |
| SciSparc Ltd. | 2.19 Million USD | 4823.634% |
| Vericel Corporation | 135.57 Million USD | 176.511% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -414012.34% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -334710.535% |
| Generation Bio Co. | -73.91 Million USD | -40.346% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -23637.071% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 289.917% |
| Invivyd, Inc. | -2.02 Million USD | -5014.941% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 65.52% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -100183.261% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 207.641% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 205.538% |
| ADMA Biologics, Inc. | 88.21 Million USD | 217.585% |
| Clene Inc. | 533 Thousand USD | 19561.726% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 530.255% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -10739.185% |
| GeoVax Labs, Inc. | -20.72 Million USD | -400.614% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 5317.857% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -53282.634% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 308.274% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1362.648% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -12308.014% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 224.355% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 141979.582% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 295.122% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 40.105% |
| Trevena, Inc. | 1.45 Million USD | 7229.278% |
| Surrozen, Inc. | -27.23 Million USD | -280.944% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -29285.552% |
| Cingulate Inc. | -582.91 Thousand USD | -17695.127% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -334516.129% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -426.58% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1370190.621% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -11674.234% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 115.239% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -10399.089% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -184009.545% |
| Kronos Bio, Inc. | 1.37 Million USD | 7660.569% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -93.29% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -35424.315% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -21142.684% |
| ImmunityBio, Inc. | -17.89 Million USD | -479.827% |
| Korro Bio, Inc. | -3.63 Million USD | -2757.603% |
| Kineta, Inc. | 5.43 Million USD | 2009.277% |
| BioVie Inc. | -229.37 Thousand USD | -45122.93% |
| Codexis, Inc. | 57.33 Million USD | 280.924% |
| Celularity Inc. | 6.75 Million USD | 1635.618% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 2684.874% |
| Celcuity Inc. | -142.77 Thousand USD | -72555.002% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 205142.499% |
| Cibus, Inc. | 1.42 Million USD | 7394.726% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -27635.561% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -352.598% |
| IN8bio, Inc. | -2.5 Million USD | -4047.581% |
| Kodiak Sciences Inc. | -25.94 Million USD | -299.78% |
| Annexon, Inc. | -3.26 Million USD | -3075.115% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -4974.902% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -148.535% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 16307.969% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 113.324% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 159.976% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -5359.526% |
| Arcellx, Inc. | 108.27 Million USD | 195.8% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -220.464% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 230.967% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -390.408% |
| Moolec Science SA | -143.3 Thousand USD | -72284.774% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -145.123% |
| Geron Corporation | -123.5 Million USD | 16.009% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 3255.796% |
| Royalty Pharma plc | 1.79 Billion USD | 105.782% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -47.997% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -2871743.854% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 44929.315% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 6.896% |
| Humacyte, Inc. | -76.55 Million USD | -35.508% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -10828.555% |
| 89bio, Inc. | -273 Thousand USD | -37896.703% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -8152.267% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -12132.429% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -84234.146% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 9369.973% |
| Notable Labs, Ltd. | 113 Thousand USD | 91897.345% |
| Liquidia Corporation | 14.6 Million USD | 810.486% |
| Mustang Bio, Inc. | -2.22 Million USD | -4562.067% |
| Immunovant, Inc. | -231 Thousand USD | -44805.195% |
| Quantum-Si incorporated | 488 Thousand USD | 21356.352% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -86.704% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -345670.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 5670.945% |
| Acasti Pharma Inc. | -11 Thousand USD | -942909.091% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -50595.201% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -15896.663% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 38.075% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 9242.678% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -27125.984% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -5197.804% |
| PepGen Inc. | -1.18 Million USD | -8661.064% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -81577.953% |
| United Therapeutics Corporation | 2.07 Billion USD | 105.011% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -353.033% |
| Solid Biosciences Inc. | -76.56 Million USD | -35.485% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -125508.176% |
| Immuneering Corporation | -764.13 Thousand USD | -13474.904% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 156642.014% |
| Belite Bio, Inc | -399 Thousand USD | -25897.744% |
| XOMA Corporation | 3.86 Million USD | 2786.636% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -417.723% |
| Bionomics Limited | -434.44 Thousand USD | -23776.45% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -9558.38% |
| uniQure N.V. | 2.21 Million USD | 4783.115% |
| Cassava Sciences, Inc. | -89.42 Million USD | -16.0% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -12.667% |
| Forte Biosciences, Inc. | -9000.00 USD | -1152466.667% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -12322.874% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -23637.071% |
| Altimmune, Inc. | -65.37 Million USD | -58.676% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 128.653% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -9558.38% |
| Compugen Ltd. | 31.45 Million USD | 429.776% |
| Peak Bio, Inc. | 367.76 Thousand USD | 28305.477% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 523.116% |
| Benitec Biopharma Inc. | 108 Thousand USD | 96147.222% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -132888.462% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -8522.693% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -5593.249% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -87068.908% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -8522.693% |
| Instil Bio, Inc. | -4.75 Million USD | -2081.056% |
| argenx SE | 1.1 Billion USD | 109.358% |
| Immunome, Inc. | -8.9 Million USD | -1064.601% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -5388.413% |
| Verona Pharma plc | -679.62 Thousand USD | -15162.998% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -59174.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | -4249.308% |
| CervoMed Inc. | -1.29 Million USD | -7918.617% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -4209.555% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -2071.467% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 4297.936% |
| Moolec Science SA | -143.3 Thousand USD | -72284.774% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -25322.395% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -3782.834% |
| AnaptysBio, Inc. | 14.78 Million USD | 801.786% |
| Design Therapeutics, Inc. | -537 Thousand USD | -19216.76% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -24192.974% |
| NeurAxis, Inc. | 2.15 Million USD | 4909.7% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 4933.691% |
| Lumos Pharma, Inc. | 2 Million USD | 5268.46% |
| Achilles Therapeutics plc | -4.73 Million USD | -2092.457% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -59174.857% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -98060.397% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 427.653% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 12132.293% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -9951.453% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -127.74% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 241334.884% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -12519.343% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -788249.293% |
| Palisade Bio, Inc. | 246 Thousand USD | 42267.073% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -314236.364% |
| Beam Therapeutics Inc. | -59.67 Million USD | -73.835% |
| Neurogene Inc. | -3.26 Million USD | -3079.982% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 174.447% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -2709.615% |
| Sesen Bio, Inc. | 40 Million USD | 359.328% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -34826.263% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -2475.864% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -984.372% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 836.726% |
| Athira Pharma, Inc. | -969 Thousand USD | -10604.954% |
| Vaccinex, Inc. | -16 Million USD | -548.157% |
| HCW Biologics Inc. | -574.82 Thousand USD | -17945.697% |
| XOMA Corporation | 3.86 Million USD | 2786.636% |
| Nektar Therapeutics | 53.47 Million USD | 293.969% |
| Arvinas, Inc. | 71.8 Million USD | 244.472% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -24.287% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -65.243% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -32114.596% |
| Rezolute, Inc. | -36 Thousand USD | -288041.667% |
| Clene Inc. | 533 Thousand USD | 19561.726% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -8078638.318% |
| BeyondSpring Inc. | 1.75 Million USD | 6024.101% |
| Synlogic, Inc. | -1.92 Million USD | -5291.424% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -280254.054% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1538.203% |
| Peak Bio, Inc. | 367.76 Thousand USD | 28305.477% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -447.018% |
| Krystal Biotech, Inc. | 47.6 Million USD | 317.899% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 173.521% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 2164.299% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -3906.266% |
| MannKind Corporation | 136.19 Million USD | 176.166% |
| Ikena Oncology, Inc. | -50.49 Million USD | -105.44% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 195.329% |
| Gossamer Bio, Inc. | -4.38 Million USD | -2265.587% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -41063.095% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2074520.0% |
| Legend Biotech Corporation | 140.92 Million USD | 173.605% |
| Mural Oncology plc | -2.56 Million USD | -3940.943% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -18725.953% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -103631.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 599.812% |
| REGENXBIO Inc. | 53.02 Million USD | 295.612% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1836.381% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -53821.248% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -5889.088% |
| Vaxart, Inc. | -60.76 Million USD | -70.714% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -39374.465% |
| Cellectis S.A. | 18 Thousand USD | 576383.333% |
| Longeveron Inc. | 221 Thousand USD | 47037.104% |
| Repare Therapeutics Inc. | -80.07 Million USD | -29.55% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 109.491% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -7916.306% |
| Revolution Medicines, Inc. | -399.66 Million USD | 74.045% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -296274.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 211795.918% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 101.205% |
| Denali Therapeutics Inc. | -93.34 Million USD | -11.126% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -414012.34% |
| Veru Inc. | 7.56 Million USD | 1471.028% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -68596.026% |
| Cingulate Inc. | -582.91 Thousand USD | -17695.127% |
| Passage Bio, Inc. | -3.72 Million USD | -2687.718% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -861167.021% |
| Exicure, Inc. | -1.42 Million USD | -7189.599% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -26983.812% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 3937.625% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -20133.286% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 252.263% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -69235.659% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -75.204% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 26629.668% |
| OmniAb, Inc. | 14.66 Million USD | 807.241% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 618.837% |
| Lipocine Inc. | -2.85 Million USD | -3538.64% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -5528.378% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1718.247% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -6786.518% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 237.728% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -159486.154% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 223.056% |
| Ocugen, Inc. | -33.53 Million USD | -209.303% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -3180.55% |
| Q32 Bio Inc. | 578 Thousand USD | 18046.54% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -39043.774% |
| Alumis Inc. Common Stock | -1.28 Million USD | -7978.738% |
| Equillium, Inc. | 35.95 Million USD | 388.478% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -5976.801% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 20818.065% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -2509116.255% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -39950.579% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 24639.403% |
| Dominari Holdings Inc. | 2.03 Million USD | 5187.347% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -56438.09% |
| vTv Therapeutics Inc. | -13.59 Million USD | -663.008% |
| Bio-Techne Corporation | 773.07 Million USD | 113.418% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 698.943% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 122.512% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -8773.482% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -332.573% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 986.817% |
| Nkarta, Inc. | -5.86 Million USD | -1667.439% |
| BioCardia, Inc. | -7.24 Million USD | -1330.97% |
| Iterum Therapeutics plc | -1.75 Million USD | -5827.486% |